Circulating miRNAs as Novel Diagnostic Biomarkers in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis

Figure 4

Forest plots of positive likelihood ratio (a), negative likelihood ratio (b), and diagnostic odds ratio (c) of circulating miRNAs for diagnosing nonalcoholic fatty liver disease among 17 studies. Forest plots of positive likelihood ratio (d), negative likelihood ratio (e), and diagnostic odds ratio (f) of microRNA-122 for diagnosing nonalcoholic fatty liver disease among four studies.

(a)

(b)

(c)

(d)

(e)

(f)